A study showed Ireland has the lowest availability for new cancer medicines in Western Europe. Of the 56 oncology medicines which were granted a European Medicines Agency (EMA) licence since 2020, only 14, or 25%, are currently available in Ireland.
It comes as figures show Ireland has the lowest availability for new cancer medicines in Western Europe, according to the Irish Pharmaceutical Healthcare Association (IPHA).
The United Cancer Advocates Network (UCAN) said there is no early access scheme in Ireland, so Irish patients are forced to wait for full assessments and negotiations with drug companies to take place.
“Medical Oncologists have a very peripheral role (and very little influence) in the HSE system for drug reimbursement. So far, to my knowledge, every approach made by medical oncologists to the HSE to address this issue has been listened to but ignored fully.” @mccarthymt7
https://www.rte.ie/news/health/2025/0507/1511477-cancer-drugs-ireland/
Lynch Syndrome Ireland 
This delay is unacceptable. Thank you for your post.
LikeLike